The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tyra Biosciences Inc shares valued at $93,596 were sold by KAPLAN GILLA on Jun 18 ’25. At $9.78 per share, KAPLAN GILLA sold 9,568 shares. The insider’s holdings dropped to 28,231 shares worth approximately $0.28 million following the completion of this transaction.
Also, KAPLAN GILLA sold 10 shares, netting a total of over 104 in proceeds. Following the sale of shares at $10.35 each, the insider now holds 37,799 shares.
Before that, GILLA KAPLAN had added 9,568 shares to its account. In a trade valued at $93,596, the Director bought Tyra Biosciences Inc shares for $9.78 each.
Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of October 18, 2024, BofA Securities has increased its “Neutral” rating to a “Buy” for TYRA. Earlier on August 15, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for TYRA stock.
Analyzing TYRA Stock Performance
On last trading session,, Tyra Biosciences Inc [NASDAQ: TYRA] rose 3.40% to $10.05. The stock’s lowest price that day was $9.76, but it reached a high of $10.4 in the same session. During the last five days, there has been a surge of approximately 4.36%. Over the course of the year, Tyra Biosciences Inc shares have dropped approximately -37.15%. Shares of the company reached a 52-week high of $17.27 on 01/15/25 and a 52-week low of $6.42 on 04/09/25.
Support And Resistance Levels for Tyra Biosciences Inc (TYRA)
According to the 24-hour chart, there is a support level at 9.74, which, if violated, would cause prices to drop to 9.43. In the upper region, resistance lies at 10.38. The next price resistance is at 10.71. RSI (Relative Strength Index) is 53.44 on the 14-day chart, showing neutral technical sentiment.
Is Tyra Biosciences Inc subject to short interest?
Stocks of Tyra Biosciences Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.16 million shares to 5.26 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 5.1 million shares. A jump of 3.02% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 15.44 of the overall float, the days-to-cover ratio (short ratio) jumped to 15.44.
Which companies own the most shares of Tyra Biosciences Inc (TYRA)?
In terms of Tyra Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 32 in the next 12 months, up nearly 229.22% from the previous closing price of $9.72. Analysts anticipate Tyra Biosciences Inc stock to reach 33 by 2025, with the lowest price target being 30. In spite of this, 2 analysts ranked Tyra Biosciences Inc stock as Buy at the end of 2025. On December 15, 2023, BofA Securities assigned a price target of “a Neutral” to the stock and downgraded coverage with a $15.
